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(1995) Extra-pancreatic manifestations in diabetes secondary to mitochondrial DNA point mutation within the tRNA Leu [1] . This observation is an interesting counter evidence against the suggested role for AII in the modulation of renal sensitivity to insulin [2, 3] . This animal study with renal insulin receptor, however, may not exclude the possibilities that: 1) AII may modulate the post-receptor transignalling steps; 2) rat kidney may not be the most ideal candidate organ for evaluating insulin action (sensitivity); and 3) one cannot exclude the possibility that modulation of the insulin sensitivity by captopril [4,5] might also be mediated by kinin [5] . We, therefore, measured the insulin receptor tyrosine kinase activity, the key step of post-insulin receptor transignalling pathway, in human adipocytes to assess whether AII and bradykinin (BK) would enhance the insulin action. AII receptors have been shown to exist in rat [6, 7] and human adipocytes [6] . Adipocytes from surgically removed fat tissue were incubated with insulin to activate the receptor tyrosine kinase, with and without the presence of AII and BK. We observed that insulin increased the insulin receptor tyrosine kinase activity, measured according to the method by Klein et al. [8] , in a dose-dependent manner (Fig. 1) . Meanwhile, neither AII nor BK had an influence on the insulin-stimulated tyrosine kinase activity, even at the maximum concentration applied: 0.46 (saline), 0.44 (AII) and 0.43 (BK)fmolP × fmol BA ±1 × min ±1 (Fig. 1 ). These observations suggest that AII and BK have no effect on the insulin-stimulated insulin receptor tyrosine kinase activity in human adipocytes. , which maps to chromosome 4 q.12, has been reported to be associated with non-insulin-dependent diabetes mellitus (NIDDM) and glucose metabolism in some populations [1, 2] . However, the relationship between the Gc genotype and Japanese NIDDM has not been examined before. The aim of this study was to determine the association of the Gc genotype with NIDDM in Japanese patients. We studied 208 NIDDM patients and 209 control subjects who showed normal glucose tolerance in a 75-g oral glucose tolerance test. Genetic polymorphisms at codon 335, 416, 420, and 429 were determined by polymerase chain reaction ± restriction fragment length polymorphism (PCR-RFLP) analysis [3] . The Gc genotypes were also examined by the isoelectric focusing (IEF) technique. The distribution of the Gc genotypes, as shown in Table 1 , indicated that the Gc 1F8/1F genotype was decreased in Japanese NIDDM patients compared to the control subjects (11.06 % vs 19.14 %, respectively, p < 0.01). The frequency of the Gc 1S/2 genotype was higher in NIDDM patients than in the control subjects (48.08 % vs 27.75 %, respectively, p < 0.02). The allele frequency of the 1F allele was significantly lower in NIDDM patients compared with control subjects (27.4 % vs 41.15 %, respectively, p < 0.02), and NIDDM showed a higher incidence of Gc 1S (34.62 % vs 27.99 %, respectively) and Gc 2 (36.3 % vs 28.47 %, respectively), although the differences were not statistically significant.
The present results suggest that the association of Gc and NIDDM is replicated in the Japanese population. One possible mechanism would be that Gc influences glucose metabolism by affecting the activity of vitamin D which might be correlated with glucose tolerance [4] . However, any direct involvement of vitamin D in insulin secretion and insulin resistance is still unclear. The other possibility is obviously that the association of Gc with NIDDM reflects the linkage of NIDDM with a hitherto unknown gene. 
